BioticsAI is a platform designed for obstetricians, aiming to improve prenatal diagnostics by mitigating errors in ultrasound exams. The AI system plugs into ultrasound machines and helps detect fetal abnormalities and pregnancy issues. BioticsAI – a member of the StartUp Health community since 2021 – won first place at TechCrunch Disrupt 2023, where the company demonstrated its live technology in front of judges and received widespread recognition.
Robhy Bustami, CEO & Co-founder of BioticsAI, joined us in the StartUp Health Studio at HLTH 2024 to chat about how his company's platform addresses the problem of misdiagnosis in prenatal screenings, which affects half of fetal malformation cases. BioticsAI has shown significant improvements in ultrasound accuracy and enhanced workflow efficiency for clinicians. The company is now preparing for FDA clearance and a national rollout.
Highlights
🏆 TechCrunch Disrupt Victory: BioticsAI won first place at TechCrunch Disrupt 2023, showcasing its innovative solution to improve prenatal ultrasound accuracy.
🤖 AI-Driven Ultrasound Accuracy: The AI platform helps obstetricians detect fetal abnormalities, reducing operator-dependent errors in ultrasound diagnostics.
🌍 Global Problem: Misdiagnosis in prenatal care affects millions globally, with half of fetal malformation cases missed due to errors in ultrasound interpretation.
📈 High Accuracy and Improved Workflow: BioticsAI’s algorithm boasts a 98% diagnostic accuracy and increases the completeness of ultrasound scans from 70% to 90%.
🏥 FDA Submission and Market Expansion: The company is on track for FDA clearance and plans to scale its technology in health systems nationwide, with a fundraising round set for the upcoming year.
---
Apply to Join a Health Moonshot Community: www.startuphealth.com/
Connect with StartUpHealth:
Website: www.startuphealth.com/
Instagram: www.instagram.com/startuphealth/
Twitter: twitter.com/startuphealth
Podcast: startup-health-now.blubrry.net/
StartUp Health